Peter Andiné

2.4k total citations
55 papers, 2.0k citations indexed

About

Peter Andiné is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Peter Andiné has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Psychology, 15 papers in Cellular and Molecular Neuroscience and 15 papers in Psychiatry and Mental health. Recurrent topics in Peter Andiné's work include Psychopathy, Forensic Psychiatry, Sexual Offending (15 papers), Neuroscience and Neuropharmacology Research (15 papers) and Schizophrenia research and treatment (12 papers). Peter Andiné is often cited by papers focused on Psychopathy, Forensic Psychiatry, Sexual Offending (15 papers), Neuroscience and Neuropharmacology Research (15 papers) and Schizophrenia research and treatment (12 papers). Peter Andiné collaborates with scholars based in Sweden, United Kingdom and Denmark. Peter Andiné's co-authors include Henrik Hagberg, Mats Sandberg, Ingemar Jacobson, Lars Hillered, Lennart Persson, R. Gill, Anders Lehmann, Ingemar Kjellmer, Eric Gilland and Owe Orwar and has published in prestigious journals such as PLoS ONE, Brain Research and FEBS Letters.

In The Last Decade

Peter Andiné

51 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Andiné Sweden 22 877 535 506 250 236 55 2.0k
Neil G. Harris United States 30 807 0.9× 534 1.0× 481 1.0× 148 0.6× 957 4.1× 85 2.4k
Fokko J. Bosker Netherlands 31 984 1.1× 608 1.1× 146 0.3× 164 0.7× 112 0.5× 82 2.6k
Irit Gil‐Ad Israel 33 694 0.8× 724 1.4× 150 0.3× 146 0.6× 211 0.9× 105 3.1k
Norihito Yamada Japan 24 735 0.8× 406 0.8× 152 0.3× 106 0.4× 183 0.8× 118 1.9k
Neil M. Richtand United States 31 1.0k 1.2× 779 1.5× 195 0.4× 97 0.4× 167 0.7× 59 2.8k
James N. Reynolds Canada 36 1.3k 1.4× 914 1.7× 2.1k 4.1× 205 0.8× 108 0.5× 141 4.1k
Ágnes Rimanóczy Hungary 25 460 0.5× 386 0.7× 228 0.5× 124 0.5× 77 0.3× 59 1.5k
William T. Regenold United States 26 482 0.5× 517 1.0× 137 0.3× 318 1.3× 204 0.9× 54 2.3k
Toshihito Suzuki Japan 27 463 0.5× 416 0.8× 85 0.2× 136 0.5× 193 0.8× 96 1.9k
Ghanshyam N. Pandey United States 31 646 0.7× 718 1.3× 106 0.2× 275 1.1× 69 0.3× 53 2.7k

Countries citing papers authored by Peter Andiné

Since Specialization
Citations

This map shows the geographic impact of Peter Andiné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Andiné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Andiné more than expected).

Fields of papers citing papers by Peter Andiné

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Andiné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Andiné. The network helps show where Peter Andiné may publish in the future.

Co-authorship network of co-authors of Peter Andiné

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Andiné. A scholar is included among the top collaborators of Peter Andiné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Andiné. Peter Andiné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virtanen, Suvi, et al.. (2025). Pharmacological treatment and psychiatric polypharmacy in forensic psychiatric care in Sweden. European Psychiatry. 68(1). e78–e78.
2.
Svensson, Olof, et al.. (2023). Experts' decision-making processes in Swedish forensic psychiatric investigations: A case vignette study. International Journal of Law and Psychiatry. 92. 101947–101947. 2 indexed citations
3.
Nilsson, Thomas, et al.. (2023). Criminal recidivism of patients in Swedish forensic psychiatry: A register-based comparison study. International Journal of Law and Psychiatry. 88. 101884–101884. 1 indexed citations
4.
Zetterberg, Henrik, et al.. (2023). Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study. Frontiers in Psychiatry. 14. 1176266–1176266. 3 indexed citations
6.
Svensson, Olof, et al.. (2021). The decision-making process in Swedish forensic psychiatric investigations. International Journal of Law and Psychiatry. 80. 101709–101709. 11 indexed citations
7.
Andiné, Peter, et al.. (2021). Structural Brain Correlates of the Externalizing Spectrum in Young Adults. Neuroscience. 463. 1–13.
8.
Nilsson, Thomas, et al.. (2021). A Static-99R Validation Study on Individuals With Mental Disorders: 5 to 20 Years of Fixed Follow-Up After Sexual Offenses. Frontiers in Psychology. 12. 625996–625996. 2 indexed citations
9.
Andiné, Peter, et al.. (2019). Focus on Brain Health to Improve Care, Treatment, and Rehabilitation in Forensic Psychiatry. Frontiers in Psychiatry. 10. 840–840. 7 indexed citations
10.
Nilsson, Thomas, Nóra Kerekes, Peter Andiné, et al.. (2010). Mentally disordered criminal offenders in the Swedish criminal system. International Journal of Law and Psychiatry. 33(4). 220–226. 41 indexed citations
11.
Andiné, Peter, Lars Rönnbäck, & Bengt Järvholm. (1997). Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities. Acta Psychiatrica Scandinavica. 96(1). 82–83. 26 indexed citations
12.
Bågenholm, Ralph, Peter Andiné, & Henrik Hagberg. (1996). Effects of the 21-Amino Steroid Tirilazad Mesylate (U-74006F) on Brain Damage and Edema after Perinatal Hypoxia-Ischemia in the Rat. Pediatric Research. 40(3). 399–403. 21 indexed citations
13.
Andiné, Peter, Rolf Axelsson, & Ingemar Jacobson. (1995). The effect of anosmia on MK-801-induced behaviour in mice. Neuroscience Letters. 190(2). 113–116. 9 indexed citations
14.
Puka‐Sundvall, Małgorzata, Henrik Hagberg, & Peter Andiné. (1994). Changes in extracellular calcium concentration in the immature rat cerebral cortex during anoxia are not influenced by MK-801. Developmental Brain Research. 77(1). 146–150. 21 indexed citations
16.
Hagberg, Henrik, et al.. (1993). Upregulation of calpain activity in neonatal rat brain after hypoxic-ischemia. Brain Research. 630(1-2). 289–294. 39 indexed citations
17.
Andiné, Peter. (1993). Involvement of adenosine in ischemic and postischemic calcium regulation. Molecular and Chemical Neuropathology. 18(1-2). 35–49. 18 indexed citations
18.
Andiné, Peter, Owe Orwar, Ingemar Jacobson, Mats Sandberg, & Henrik Hagberg. (1991). Changes in Extracellular Amino Acids and Spontaneous Neuronal Activity During Ischemia and Extended Reflow in the CA1 of the Rat Hippocampus. Journal of Neurochemistry. 57(1). 222–229. 98 indexed citations
20.
Kjellmer, Ingemar, Peter Andiné, Henrik Hagberg, & Klara Thiringer. (1989). Extracellular increase of hypoxanthine and xanthine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Brain Research. 478(2). 241–247. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026